Reduced DNA-dependent protein kinase activity is associated with lung cancer

D H Auckley1, R E Crowell, E R Heaphy

  • 1Division of Pulmonary, Critical Care and Allergy, University of New Mexico and the New Mexico Veterans Health Care System, Albuquerque, NM 87108, USA.

Carcinogenesis
|April 27, 2001
PubMed

Insights

Reduced DNA repair capacity, specifically DNA-dependent protein kinase (DNA-PK) activity, is linked to increased lung cancer risk. Lower DNA-PK activity in individuals correlates with a higher susceptibility to developing lung cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Reduced DNA repair capacity for carcinogen-induced DNA damage is a key factor in inherent susceptibility to lung cancer.
  • DNA-dependent protein kinase (DNA-PK) is a critical enzyme involved in DNA double-strand break repair and transcriptional control.

Purpose of the Study:

  • To investigate interindividual variations in DNA-PK activity.
  • To determine the association between DNA-PK activity levels and lung cancer risk.

Main Methods:

  • DNA-PK activity was measured in peripheral mononuclear cells (PMNs) from lung cancer patients (n=41) and healthy controls (n=41).
  • Enzyme activity in PMNs was correlated with activity in bronchial epithelial cells.
  • The effect of DNA-PK activity on bronchial epithelial cell growth after bleomycin exposure was assessed.

Main Results:

  • Significant differences in DNA-PK activity distribution were observed between lung cancer cases and controls (P=0.03).
  • Fewer cases than controls exhibited high DNA-PK activity (7-10 units), while more cases had low to moderate activity (2.5-5.0 units).
  • DNA-PK activity in PMNs accurately reflected that in bronchial epithelial cells, validating PMNs as a suitable biomarker.

Conclusions:

  • Reduced DNA-PK activity is associated with an increased risk of lung cancer.
  • DNA-PK activity may serve as a potential modifier of lung cancer risk.
  • Peripheral mononuclear cells are a viable surrogate for studying DNA-PK activity in population-based lung cancer research.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...